Blood plasma treatment has limited effect for sickest #COVID-19 patients | Imperial News | Imperial College London
▻https://www.imperial.ac.uk/news/211493/blood-plasma-treatment-limited-effect-sickest
Janvier 2021
Treating critically ill COVID-19 patients with blood #plasma from people who have fought off the disease has limited impact on patient outcomes.
The early findings, which are yet to be published, come from the #REMAP-CAP study and show that treatment with convalescent plasma did not improve outcomes among patients requiring intensive care unit (ICU) support.